Ergo Bioscience Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
10
Ergo Bioscience General Information
Description
Developer of plant-based protein ingredients designed to create more realistic plant-based meat and dairy alternatives. The company utilizes precision fermentation of plant cells to develop key animal proteins, such as myoglobin and casein, which are then used to improve the taste, texture, and aroma of plant-based products, enabling the plant-based food market to offer consumers a more familiar and enjoyable meat- and dairy-free eating experience.
Contact Information
Website
www.ergobiotech.comCorporate Office
- Avenida Belgrano 758
- Sunchales, Santa Fe 2322
- Argentina
Corporate Office
- Avenida Belgrano 758
- Sunchales, Santa Fe 2322
- Argentina
Ergo Bioscience Timeline
Ergo Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 9. Early Stage VC | 31-Oct-2024 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 01-Oct-2023 | Completed | Generating Revenue | |||
| 7. Early Stage VC | 21-Sep-2023 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 25-May-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 12-Apr-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 24-Nov-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 17-Nov-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 20-Apr-2020 | $210K | $210K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Ergo Bioscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ergo Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ergo Bioscience Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Grow NY | Accelerator/Incubator | |||
| Ag-West Bio | Not-For-Profit Venture Capital | Minority | ||
| Global Agri-Food Advancement Partnership | Accelerator/Incubator | Minority | ||
| AIR Capital | Venture Capital | Minority | ||
| Pascual Innoventures | Venture Capital | Minority |
Ergo Bioscience FAQs
-
When was Ergo Bioscience founded?
Ergo Bioscience was founded in 2020.
-
Where is Ergo Bioscience headquartered?
Ergo Bioscience is headquartered in Sunchales, Argentina.
-
What is the size of Ergo Bioscience?
Ergo Bioscience has 10 total employees.
-
What industry is Ergo Bioscience in?
Ergo Bioscience’s primary industry is Food Products.
-
Is Ergo Bioscience a private or public company?
Ergo Bioscience is a Private company.
-
What is Ergo Bioscience’s current revenue?
The current revenue for Ergo Bioscience is .
-
How much funding has Ergo Bioscience raised over time?
Ergo Bioscience has raised $2.21M.
-
Who are Ergo Bioscience’s investors?
Grow NY, Ag-West Bio, Global Agri-Food Advancement Partnership, AIR Capital, and Pascual Innoventures are 5 of 10 investors who have invested in Ergo Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
